Home
>
National Drug Code (NDC)
>
Namenda
Namenda - 55154-4617-7 - (Memantine Hydrochloride)
Drug Information of Namenda
| Product NDC: | 55154-4617 |
| Proprietary Name: | Namenda |
| Non Proprietary Name: | Memantine Hydrochloride |
| Active Ingredient(s): | 5 mg/1 & nbsp; Memantine Hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Namenda
| Product NDC: | 55154-4617 |
| Labeler Name: | Cardinal Health |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021487 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20031016 |
Package Information of Namenda
| Package NDC: | 55154-4617-7 |
| Package Description: | 14 TABLET in 1 BLISTER PACK (55154-4617-7) |
NDC Information of Namenda
| NDC Code | 55154-4617-7 |
| Proprietary Name | Namenda |
| Package Description | 14 TABLET in 1 BLISTER PACK (55154-4617-7) |
| Product NDC | 55154-4617 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Memantine Hydrochloride |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20031016 |
| Marketing Category Name | NDA |
| Labeler Name | Cardinal Health |
| Substance Name | MEMANTINE HYDROCHLORIDE |
| Strength Number | 5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | NMDA Receptor Antagonists [MoA],N-methyl-D-aspartate Receptor Antagonist [EPC] |
